RecallDepth
Class II Ongoing

Cephalexin for Oral Suspension, USP, 125 mg per 5 mL, 100 mL (when mixed), Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascent Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-544-88

Company
Ascend Laboratories, Llc
Recall Initiated
May 23, 2025
Posted
June 18, 2025
Recall Number
D-0468-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
48,936 - 100 mL bottles
Firm Location
Parsippany, NJ, United States

Reason for Recall

Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis. The individual impurity was identified to be Cephalexin Glucose Adduct.

Distribution

Nationwide in the USA.

Lot / Code Info

Lot #: 23141828, 23141829, Exp Date: 5/31/2025; 23142342, Exp Date: 6/30/2025; 23142708, Exp Date: 7/31/2025; 23144035, Exp Date: 10/31/2025; 23144270, Exp Date: 11/302025; 24140026, Exp Date: 12/31/2025

More recalls by Ascend Laboratories, Llc

View all recalls by this company →

Other recent Class II Drug recalls